Date: February 13 – 15, 2020
Location: Moscone West Building, San Francisco, CA
Location: Moscone West Building, San Francisco, CA
In collaboration with Mayo Clinic, Lee Moffitt Cancer Center, Monash University, and Kintor Pharmaceuticals, we are proud to announce our 3 abstracts in prostate cancer at the American Society of Clinical Oncology – Genitourinary Cancers Symposium. Stop by our poster presentations or schedule a meeting with us here.
Abstracts: (click on the title to view abstract)
- Abstract 160 | Poster G18 | Thursday, Feburary 13 | 11:30am – 1:00pm
Plasma circulating tumor DNA (ctDNA) based clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC) - Abstract 176 | Poster H12 | Thursday, February 13 | 11:30am – 1:00pm
Plasma cell-free DNA (cfDNA) profiling of copy number variation (CNV) to identify poor prognostic biomarkers in metastatic castration-resistant prostate cancer (mCRPC) - Abstract 186 | Poster H22 | Thursday, Februrary 13 | 11:30am – 1:oopm
Biomarker analysis (CTC and ctDNA/RNA) of GT0918 (Proxalutamide) new AR blocker in phase I mCRPC patients with dos escalation